Avicanna (AVCNF) News Today $0.21 0.00 (0.00%) As of 03/31/2025 Add Compare Share Share Headlines Stock AnalysisChartHeadlinesBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 Time Period Avicanna Announces Late Filing of Financial Statements and Application for Management Cease Trade OrderMarch 31 at 8:10 PM | globenewswire.comAvicanna To Hold Full Year 2024 Earnings Conference CallMarch 18, 2025 | globenewswire.comAvicanna Announces Scientific and Medical Affairs Collaboration with Vectura Fertin PharmaJanuary 16, 2025 | globenewswire.comAvicanna completes first delivery of topical products to pharmaceutical companyDecember 3, 2024 | markets.businessinsider.comAvicanna Completes First Delivery of Proprietary Topical Products to Multinational Pharmaceutical CompanyDecember 2, 2024 | financialpost.comAvicanna Completes First Delivery of Proprietary Topical Products to Multinational Pharmaceutical CompanyDecember 2, 2024 | globenewswire.comAvicanna Inc. Reports Strong Growth in Q3 2024November 26, 2024 | markets.businessinsider.comAvicanna Third Quarter 2024 Earnings: CA$0.008 loss per share (vs CA$0.016 loss in 3Q 2023)November 18, 2024 | finance.yahoo.comAvicanna Inc. (AVCN.TO)November 17, 2024 | finance.yahoo.comAvicanna Shows Strong Revenue Growth and Improved MarginsNovember 16, 2024 | markets.businessinsider.comAvicanna Reduces Net Loss And Improves Gross Profit, Focusing On International MarketsNovember 15, 2024 | benzinga.comAvicanna Inc.: Avicanna Reports Q3 2024November 15, 2024 | finanznachrichten.deAvicanna Reports Q3 2024November 14, 2024 | globenewswire.comAvicanna Announces Closing of Non-Brokered Private PlacementNovember 4, 2024 | globenewswire.comAVCN:CA Avicanna Inc.October 19, 2024 | seekingalpha.comAvicanna announces medical cannabis study through MyMedi.caSeptember 24, 2024 | msn.comCBD's Toxicity Concerns: Could Europe Ban Cannabidiol In Cosmetics?September 24, 2024 | benzinga.comAvicanna Announces Medical Cannabis Real World Evidence Study through MyMedi.caSeptember 23, 2024 | globenewswire.comAvicanna Announces Repayment of DebenturesAugust 30, 2024 | globenewswire.comAvicanna Secures Nearly $2M In Private Placement Deal Amid US Patent Win For Cannabinoid Topical FormulaAugust 29, 2024 | msn.comAvicanna Announces Closing of Non-Brokered Private PlacementAugust 28, 2024 | globenewswire.comAvicanna Inc.: Avicanna Announces United States Patent and Trademark Office Issuance of Patent on Topical TechnologyAugust 28, 2024 | finanznachrichten.deAvicanna Secures US Patent For Topical Cannabinoid Technology To Treat Pain And InflammationAugust 28, 2024 | msn.comAvicanna Announces United States Patent and Trademark Office Issuance of Patent on Topical TechnologyAugust 27, 2024 | globenewswire.comAvicanna's CBG Products Reach 19 Countries: Denmark Joins Global ExpansionAugust 16, 2024 | benzinga.comAvicanna Subsidiary Completes Export of Aureus Branded CBG into DenmarkAugust 15, 2024 | globenewswire.comAvicanna Reports Q2 2024August 14, 2024 | globenewswire.comAvicanna Announces Changes of AuditorsAugust 2, 2024 | globenewswire.comAvicanna Announces Results of Annual General Meeting & Provides Corporate UpdateJuly 10, 2024 | globenewswire.comAvicanna General MeetingJune 19, 2024 | globenewswire.comAvicanna Announces USPTO Issuance of Patent SEDDS TechnologyJune 19, 2024 | globenewswire.comAvicanna to Present at the Life Science Investor Forum June 20th, 2024June 18, 2024 | globenewswire.comAvicanna Reports Q1 2024 and First Positive Adjusted EBIDTA QuarterMay 14, 2024 | globenewswire.comCBD Helps With This Rare Blistering Skin Disorder, New Study From Avicanna Shows Promising Results In Epidermolysis Bullosa TreatmentMay 13, 2024 | benzinga.comAvicanna Announces Results of Study in Patients with Epidermolysis BullosaMay 13, 2024 | globenewswire.comAvicanna Announces Closing of Non-brokered Private PlacementApril 18, 2024 | globenewswire.comAvicanna Announces Completion of Topical Gel Observational Real-World Evidence StudyApril 10, 2024 | globenewswire.comCannabinoid-Based Products Maker Sees Triple-Digit Growth In 2023 Gross Profit, Revenue Surges 314% YoYApril 2, 2024 | msn.comAvicanna Reports Full Year 2023 Audited Financial ResultsApril 2, 2024 | globenewswire.comAvicanna Announces the Canadian Launch of 10% CBD (THC Free) Proprietary FormulationMarch 27, 2024 | globenewswire.comAvicanna To Hold Full Year 2023 Earnings Conference CallMarch 26, 2024 | finance.yahoo.comAvicanna To Hold Full Year 2023 Earnings Conference CallMarch 26, 2024 | globenewswire.comAvicanna Hosts Symposium on Cannabinoid-based MedicineFebruary 29, 2024 | globenewswire.comAvicanna Announces New Research Collaboration with a Multi-national European-based Pharmaceutical CompanyFebruary 15, 2024 | finance.yahoo.comAvicanna Announces New Research Collaboration with a Multi-national European-based Pharmaceutical CompanyFebruary 15, 2024 | finance.yahoo.comAvicanna Announces New Research Collaboration with a Multi-national European-based Pharmaceutical CompanyFebruary 15, 2024 | globenewswire.comAvicanna Obtains Its First Indication-Specific Drug Registration with Trunerox™February 13, 2024 | markets.businessinsider.comAvicanna Inc.: Avicanna Announces Supply and Licensing Agreement with Multinational Pharmaceutical CompanyFebruary 5, 2024 | finanznachrichten.deAvicanna signs supply and licensing agreement with pharmaceutical companyFebruary 5, 2024 | msn.comCBD-Focused Avicanna Taps Into European Market Via Exclusive Pharma Supply DealFebruary 5, 2024 | msn.com Remove Ads Get Avicanna News Delivered to You Automatically Sign up to receive the latest news and ratings for AVCNF and its competitors with MarketBeat's FREE daily newsletter. Email Address AVCNF Media Mentions By Week AVCNF Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. AVCNF News Sentiment▼0.000.78▲Average Medical News Sentiment AVCNF News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. AVCNF Articles This Week▼10▲AVCNF Articles Average Week Remove Ads Get Avicanna News Delivered to You Automatically Sign up to receive the latest news and ratings for AVCNF and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies TGIFF News FFNTF News ABSCF News ACRHF News LBTSF News AZFL News ERBB News AVTBF News BIOGY News BIOYF News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTC:AVCNF) was last updated on 4/1/2025 by MarketBeat.com Staff From Our PartnersNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredTrump’s Secret WeaponHave you looked at the stock market recently? Millions of investors are scrambling trying to figure out what's...American Alternative | SponsoredRetirement Nightmare? It’s Already Happening.The market is on edge. Every day, another company slashes its dividend, leaving investors scrambling. Intel...Investors Alley | SponsoredNew “Trump” currency proposed in DCA former U.S. Presidential Advisor has come forward with a stern warning to investors: “Get out of tech, no...Paradigm Press | SponsoredA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | Sponsored10X Bigger than AI, quantum, EVs, crypto, and robotics combined?World Economic Forum: "Arguably the Most Exciting Human Discovery Since Fire" Sam Altman, Bill Gates, and M...Stansberry Research | SponsoredNew Pick (93% history of rising by May 8)We just posted a new recommendation. Keep in mind: You could have boosted the Netflix trade we issued to the p...InvestorPlace | SponsoredIs Fort Knox Hiding Less Gold Than We Think? Find Out What That Means for YouWith gold prices recently soaring to record highs over $3,000 an ounce, and central banks rushing to accumulat...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Avicanna Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Avicanna With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
